Invention Grant
- Patent Title: Modulation of NLGn4 expression, NK cell activity in non-alcoholic fatty liver disease (NAFLD)
-
Application No.: US15914112Application Date: 2018-03-07
-
Publication No.: US10266897B2Publication Date: 2019-04-23
- Inventor: Rifaat Safadi
- Applicant: HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
- Applicant Address: IL Jerusalem
- Assignee: Hadasit Medical Research and Development Ltd.
- Current Assignee: Hadasit Medical Research and Development Ltd.
- Current Assignee Address: IL Jerusalem
- Agency: Roach Brown McCarthy & Gruber, P.C.
- Agent Kevin D. McCarthy
- Main IPC: C07H21/02
- IPC: C07H21/02 ; C07H21/04 ; C12Q1/6883 ; A61K31/7088 ; A61K45/06 ; C12N15/113 ; A61K31/713 ; A61K31/7105
Abstract:
A kit having a means for isolating an immune cell population from a biological sample of a patient; and at least one agent capable of detecting NLGn4 gene product expression level.
Public/Granted literature
- US20180202001A1 MODULATION OF NLGn4 EXPRESSION, NK CELL ACTIVITY IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) Public/Granted day:2018-07-19
Information query
